A Multicenter Preliminary Study of Cangrelor following Thrombectomy Failure for Refractory Proximal Intracranial Occlusions.
Gaultier MarnatFrançois DelvoyeStephanos Nikolaos FinitsisBertrand LapergueFlorent GarielDomenico ConsoliJean-Philippe DésillesMichael MazighiCyril DargazanliRomain BourcierJean DarcourtVanessa ChalumeauMahmoud ElhoranyFrederic ClarenconSébastien RichardBenjamin GoryIgor Paul Sibonnull nullPublished in: AJNR. American journal of neuroradiology (2021)
Cangrelor seems to be as safe as glycoprotein IIb/IIIa inhibitors for managing refractory intracranial occlusion and leads to satisfactory brain reperfusion. Cangrelor is a promising agent in this setting, and additional studies are warranted to confirm our findings.